OpenAI has upgraded ChatGPT Deep Research with GPT-5.2, website-specific search, and real-time controls, giving users ...

OpenAI enhances ChatGPT's Deep Research with source controls, live tracking, and a document viewer for more accurate, customizable reports..

Malaysia's economy likely expanded at its fastest pace in more than a year in the final quarter of 2025, supported by strong ...

WASHINGTON — The Justice Department is scrambling to review about 5.2 million pages related to the late convicted sex offender Jeffrey Epstein to comply with a law passed by Congress, a source ...

The Department of Justice has 5.2 million pages of Jeffrey Epstein-related documents left to review according to reports from The New York Times and Reuters. About 400 lawyers from multiple government ...

Dec 30 (Reuters) - The U.S. Justice Department revealed it has 5.2 million pages of Epstein files left to review and needs 400 lawyers from four different department offices to help with the process ...

The Justice Department is buried in about 5.2 million pages of documents potentially related to notorious pedophile Jeffrey Epstein – and it might take until late January to complete the review. The ...

The number represents a more precise, and potentially much larger, figure than earlier estimates. The department is seeking to enlist about 400 lawyers to help in the review. By Devlin Barrett ...

Deputy Attorney General Todd Blanche said the Department of Justice (DOJ) would not be releasing the full Epstein files on Friday as required under new legislation, instead sending over a partial ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the ...

OpenAI launched its latest frontier model, GPT-5.2, on Thursday amid increasing competition from Google, pitching it as its most advanced model yet and one designed for developers and everyday ...

In the POLARIX study (ClinicalTrials.gov identifier: NCT03274492), polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) showed a significant progression-free ...